Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001104659-15-066536)

Filing Details

Accession Number:
0001104659-15-066536
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-22 17:31:24
Reporting Period:
2015-09-21
Filing Date:
2015-09-22
Accepted Time:
2015-09-22 17:31:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157602 Vitae Pharmaceuticals Inc VTAE Pharmaceutical Preparations (2834) 043567753
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202285 Jr J Donald Hayden C/O Vitae Pharmaceuticals, Inc.
502 West Office Center Dr.
Fort Washington PA 19034		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-21 16,130 $3.45 16,130 No 4 M Direct
Common Stock Disposition 2015-09-21 16,130 $17.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-09-21 16,130 $0.00 16,130 $3.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,065 2016-03-28 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2015.
  2. The option vested over three years of service following March 29, 2006, with 50% vesting upon completion of one year of service and in two equal annual installments thereafter.